Literature DB >> 21430153

Intrinsic bioenergetic properties and stress sensitivity of dopaminergic synaptosomes.

Sung W Choi1, Akos A Gerencser, Donna W Lee, Subramanian Rajagopalan, David G Nicholls, Julie K Andersen, Martin D Brand.   

Abstract

Dopaminergic neurons of the substantia nigra pars compacta are defective in Parkinson's disease, but the specificity of this dysfunction is not understood. One hypothesis is that mitochondrial bioenergetic capacity is intrinsically lower in striatal dopaminergic presynaptic nerve varicosities, making them unusually susceptible to inhibition of electron transport by oxidative damage. To test this hypothesis, we separated isolated synaptosomes bearing dopamine transporters using immunomagnetic beads and compared their respiration with that of the residual nondopaminergic synaptosomes. As predicted, dopaminergic synaptosomes from striatum had lower respiratory rates. However, so did dopaminergic synaptosomes from cortex, indicating a lack of the predicted striatal specificity. We used fluorescent probes to analyze the bioenergetic competence of individual synaptosomes in the two fractions. The respiratory differences became nonsignificant when respiration rates were normalized to the number of respiration-competent synaptosomes, suggesting that differences reflected the quality of the different fractions. To circumvent damage induced by synaptosomal separation, we monitored membrane potentials in whole unseparated single synaptosomes using fluorescent imaging, and then identified the dopaminergic subpopulation using a fluorescent dopamine transporter substrate (ASP(+) [4-(4-diethylaminostyryl)-N-methylpyridinium iodide]). The capacity of dopaminergic and nondopaminergic synaptosomes to maintain plasma membrane and mitochondrial membrane potential under several stresses did not differ. In addition, this capacity did not decline in either subpopulation with age, a risk factor for Parkinson's disease. We conclude that the intrinsic bioenergetic capacities of dopaminergic and nondopaminergic presynaptic synaptosomes from mice do not differ.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430153      PMCID: PMC3083118          DOI: 10.1523/JNEUROSCI.5817-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Enlargement of synaptic size as a compensative reaction in aging and dementia.

Authors:  C Bertoni-Freddari; P Fattoretti; M Pieroni; W Meier-Ruge; J Ulrich
Journal:  Pathol Res Pract       Date:  1992-06       Impact factor: 3.250

2.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

3.  Age-dependent impairment of mitochondrial function in primate brain.

Authors:  A C Bowling; E M Mutisya; L C Walker; D L Price; L C Cork; M F Beal
Journal:  J Neurochem       Date:  1993-05       Impact factor: 5.372

4.  Morphological plasticity of synaptic mitochondria during aging.

Authors:  C Bertoni-Freddari; P Fattoretti; T Casoli; C Spagna; W Meier-Ruge; J Ulrich
Journal:  Brain Res       Date:  1993-11-19       Impact factor: 3.252

5.  Impairment of mitochondrial oxidative phosphorylation in the brain of aged mice.

Authors:  M L Ferrándiz; M Martínez; E De Juan; A Díez; G Bustos; J Miquel
Journal:  Brain Res       Date:  1994-05-02       Impact factor: 3.252

6.  Lack of major mitochondrial bioenergetic changes in cultured skin fibroblasts from aged individuals.

Authors:  R Solmi; F Pallotti; M Rugolo; M L Genova; E Estornell; P Ghetti; A Pugnaloni; G Biagini; C Rizzoli; G Lenaz
Journal:  Biochem Mol Biol Int       Date:  1994-06

7.  The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.

Authors:  P H Andersen
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

8.  Regulation of calcium concentrations in synaptosomes: alpha 2-adrenoceptors reduce free Ca2+ by closure of N-type Ca2+ channels.

Authors:  J Z Xiang; J Morton; M J Brammer; I C Campbell
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

9.  Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody.

Authors:  S M Williams; P S Goldman-Rakic
Journal:  Cereb Cortex       Date:  1993 May-Jun       Impact factor: 5.357

10.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

View more
  27 in total

1.  Brain cortex mitochondrial bioenergetics in synaptosomes and non-synaptic mitochondria during aging.

Authors:  Silvia Lores-Arnaiz; Paulina Lombardi; Analía G Karadayian; Federico Orgambide; Daniela Cicerchia; Juanita Bustamante
Journal:  Neurochem Res       Date:  2016-01-28       Impact factor: 3.996

2.  Synaptosomal lactate dehydrogenase isoenzyme composition is shifted toward aerobic forms in primate brain evolution.

Authors:  Tetyana Duka; Sarah M Anderson; Zachary Collins; Mary Ann Raghanti; John J Ely; Patrick R Hof; Derek E Wildman; Morris Goodman; Lawrence I Grossman; Chet C Sherwood
Journal:  Brain Behav Evol       Date:  2014-03-28       Impact factor: 1.808

3.  The role of mitochondrially derived ATP in synaptic vesicle recycling.

Authors:  Divya Pathak; Lauren Y Shields; Bryce A Mendelsohn; Dominik Haddad; Wei Lin; Akos A Gerencser; Hwajin Kim; Martin D Brand; Robert H Edwards; Ken Nakamura
Journal:  J Biol Chem       Date:  2015-06-30       Impact factor: 5.157

Review 4.  Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

Review 5.  Mitochondrial bioenergetics and neuronal survival modelled in primary neuronal culture and isolated nerve terminals.

Authors:  David G Nicholls; Martin D Brand; Akos A Gerencser
Journal:  J Bioenerg Biomembr       Date:  2014-08-30       Impact factor: 2.945

Review 6.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

7.  Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.

Authors:  Hae-Young Hawong; Joseph R Patterson; Brittany M Winner; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2015-07-02       Impact factor: 3.252

Review 8.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

9.  Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress.

Authors:  Qian Sun; Wentao Gao; Patricia Loughran; Rick Shapiro; Jie Fan; Timothy R Billiar; Melanie J Scott
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

10.  Alteration in glutathione content and associated enzyme activities in the synaptic terminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains.

Authors:  G Harish; Anita Mahadevan; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.